TMC Life Sciences Bhd Total Liabilities
TMC Life Sciences Bhd total liabilities. Based on the latest financial reports, TMC Life Sciences Bhd (0101) has total liabilities worth RM247.86 Million MYR (≈ $62.23 Million USD) as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are TMC Life Sciences Bhd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of TMC Life Sciences Bhd (2006–2026)
Total liabilities of TMC Life Sciences Bhd from 2006 to 2026. This chart illustrates how TMC Life Sciences Bhd's total liabilities have evolved over time, based on quarterly financial data.
TMC Life Sciences Bhd Competitors by Total Liabilities
The table below lists competitors of TMC Life Sciences Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baticim Bati Anadolu Cimento Sanayi AS
IS:BTCIM
|
Turkey | TL11.69 Billion |
|
Galan Lithium Limited
F:9CH
|
Germany | €14.42 Million |
|
Kao Hsiung Chang Iron & Steel Corp
TW:2008
|
Taiwan | NT$4.62 Billion |
|
Wah Hong Industrial
TWO:8240
|
Taiwan | NT$3.07 Billion |
|
Jikai Equipment Manufacturing Co Ltd
SHE:002691
|
China | CN¥295.59 Million |
|
Malayan Flour Mills Bhd
KLSE:3662
|
Malaysia | RM922.77 Million |
|
Solarius Capital Acquisition Corp.
NASDAQ:SOCA
|
USA | $7.82 Million |
|
Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret AS
IS:MOBTL
|
Turkey | TL3.83 Billion |
Liability Composition Analysis (2006–2026)
This chart breaks down TMC Life Sciences Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 0101 total assets.
Liquidity & Leverage Metrics
TMC Life Sciences Bhd Total Liabilities Ratios Explained
TMC Life Sciences Bhd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TMC Life Sciences Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TMC Life Sciences Bhd (2006–2026)
The table below shows the annual total liabilities of TMC Life Sciences Bhd from 2006 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-08-31 | RM247.86 Million ≈ $62.23 Million |
-11.21% |
| 2025-08-31 | RM279.15 Million ≈ $70.08 Million |
-7.47% |
| 2024-08-31 | RM301.69 Million ≈ $75.74 Million |
-4.18% |
| 2023-08-31 | RM314.84 Million ≈ $79.04 Million |
+3.07% |
| 2022-08-31 | RM305.46 Million ≈ $76.69 Million |
+12.88% |
| 2021-08-31 | RM270.61 Million ≈ $67.94 Million |
+51.75% |
| 2020-08-31 | RM178.32 Million ≈ $44.77 Million |
+106.68% |
| 2019-08-31 | RM86.28 Million ≈ $21.66 Million |
+40.06% |
| 2018-08-31 | RM61.60 Million ≈ $15.47 Million |
+11.80% |
| 2017-08-31 | RM55.10 Million ≈ $13.83 Million |
-15.90% |
| 2016-08-31 | RM65.52 Million ≈ $16.45 Million |
+72.52% |
| 2015-08-31 | RM37.98 Million ≈ $9.53 Million |
+30.31% |
| 2014-08-31 | RM29.14 Million ≈ $7.32 Million |
+15.78% |
| 2013-08-31 | RM25.17 Million ≈ $6.32 Million |
-25.09% |
| 2012-08-31 | RM33.60 Million ≈ $8.44 Million |
-57.87% |
| 2011-08-31 | RM79.77 Million ≈ $20.03 Million |
+13.60% |
| 2009-08-31 | RM70.22 Million ≈ $17.63 Million |
+26.36% |
| 2008-08-31 | RM55.57 Million ≈ $13.95 Million |
+194.99% |
| 2007-08-31 | RM18.84 Million ≈ $4.73 Million |
+61.19% |
| 2006-08-31 | RM11.69 Million ≈ $2.93 Million |
-- |
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more